Literature DB >> 29156160

Treating Charcot Arthropathy Is a Challenge: Explaining Why My Treatment Algorithm Has Changed.

Lawrence DiDomenico1, Zachary Flynn2, Michael Reed3.   

Abstract

Charcot deformity is a challenge that foot and ankle surgeons struggle to manage successfully. Despite the advances in knowledge, technology, and treatment modalities, limb loss is still greater than 10%. This article discusses the efficacy of conservative measures and traditional surgical approaches. It proposes a multidisciplinary team approach, medical optimization, and lifestyle modification to put the patient in the best position to heal. Also discussed is the authors' staged surgical treatment protocol to enhance outcomes and decrease the rate of limb loss.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Charcot; Charcot challenges; Charcot reconstruction; Diabetic limb salvage; Diabetic reconstruction; Neuroarthropathy; Staged approach to Charcot; Surgical algorithm for Charcot

Mesh:

Year:  2017        PMID: 29156160     DOI: 10.1016/j.cpm.2017.08.012

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  3 in total

1.  High rate of complications after corrective midfoot/subtalar arthrodesis and Achilles tendon lengthening in Charcot arthropathy type Sanders 2 and 3.

Authors:  Markus Regauer; Veronika Grasegger; Julian Fürmetz; Adrian Calvacanti Kussmaul; Wolfgang Böcker; Christian Ehrnthaller
Journal:  Int Orthop       Date:  2022-09-22       Impact factor: 3.479

2.  Diabetic Foot Management: How Could a Procedural Pathway Improve the Surgical Outcome?

Authors:  V Belgaid; C Courtin; R Desmarchelier; M Fessy; J L Besse
Journal:  Malays Orthop J       Date:  2020-11

Review 3.  Factors impacting the evidence-based assessment, diagnosis and management of Acute Charcot Neuroarthropathy: a systematic review.

Authors:  D Diacogiorgis; B M Perrin; M I C Kingsley
Journal:  J Foot Ankle Res       Date:  2021-04-07       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.